drugset / Trial / NCT03943004
Trial of DFP-14927 in Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase I, open-label, single-arm, dose escalation study of DFP-14927 intravenous infusion administered to patients with refractory or relapsed solid tumors.
Timeline
- Start
- 2019-09-30
- Primary completion
- 2026-03-01
- Completion
- 2026-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DFP-14927 | Unknown | — | Intravenous |